Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced the convening of its Annual General Meeting on June 26, 2025, in Shanghai. The announcement indicates that the number of shareholders who have confirmed their attendance does not exceed half of the total voting shares, which may impact the decision-making process at the meeting.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$15.70 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and services.
Average Trading Volume: 7,222,122
Technical Sentiment Signal: Buy
Current Market Cap: HK$65.28B
For an in-depth examination of 2607 stock, go to TipRanks’ Overview page.